CRVS
Corvus Pharmaceuticals, Inc. · Healthcare
Director and 10% owner Peter A. Thompson bought $501K of Corvus Pharmaceuticals, Inc.
Bought$500,723
$3.51Price
142,656Shares
+2%Stake
What CRVS did for a copier
Prices for CRVS after this filing aren't in yet.
Peter A. Thompson's record
6 other buys with 3 months of prices since 2016: on average −4.9% against the S&P 500, and 1 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Aug 6. Filed Thu, Aug 8, 5:00 PM ET, after the close. Not investment advice.